Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Repligen
85
Repligen
Technology
Biotechnology
Life Sciences
Nearly all therapeutic monoclonal antibodies (mAbs) on the market or in development are produced using bioprocessing products manufactured by Repligen
Suggest edits
Founded
1981
Raised
$4M
Follow us
Companies in the same industry
BiotechZone
Proclara Biosciences
Diasome
BioSilta
NANO.io
TriAltus Bioscience
Desktop Genetics
BioDelivery Sciences International
BeiGene
BridgeBio
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$4,000,000
Venture capital - 2014
Team Size
50+
Employees
I work here
The Motley Fool
Read This Before You Sell Repligen Corporation Stock
The Motley Fool
Repligen Corporation Jumped 14.6% in February -- Here's Why
The Motley Fool
Why Repligen Corporation Shares Are Falling --
